arrow
N

Noriko Isobe

kyushu university
H指数:34
被引数:5,491

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiancestry genome-wide association and multiomics analyses elucidate spatiocellular features of multiple sclerosis genetics

多血统全基因组关联和多组学分析阐明了多发性硬化遗传学的空间细胞特征

2026-09-070
OAAI
Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study

头痛患病率及类型在多发性硬化及相关神经免疫性疾病中的表现:一项多中心研究

2026-03-260
PRE
Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study)

日本真实世界临床环境中视神经脊髓炎谱系障碍患者应用萨他利珠单抗的长期有效性与安全性:一项多中心医疗病历回顾的2.5年最终分析(The SAkuraBeyond Study)

2026-02-240
PRE
A case of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with a challenging diagnosis due to the absence of typical skin manifestations

抗核基质蛋白2抗体阳性的无皮损性皮肌炎一例:因缺乏典型皮肤表现导致诊断困难

2026-01-010
PRE
Clinical Spectrum, Pathology, and Mechanisms of Anti-LGI4 Antibody-Positive Autoimmune Nodopathy
2025-11-010
PRE
Facilitated α-synuclein oligomer sharing among glial cells by a centrally acting connexin inhibitor attenuates a rapidly progressive multiple system atrophy-cerebellar type model by reducing the neuronal α-synuclein burden

中枢作用的连接蛋白抑制剂通过促进星形胶质细胞间的α-突触核蛋白寡聚体共享,通过减少神经元α-突触核蛋白负荷来减轻快速进展的多系统萎缩-小脑型模型。

2025-09-260
OAAI
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

日本视神经脊髓炎谱系障碍患者中萨他利珠单抗的安全性及有效性:一项为期30个月的市场后监测中期分析

2025-09-260
OAAI
Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review

日本真实世界临床环境中萨特拉利珠单抗的有效性:视神经脊髓炎谱系障碍中的白细胞介素-6受体抑制:一项多中心医疗病历回顾的六个月中期分析

2025-06-010
PRE
Objective quantification of pre-CAR-T EEG abnormalities for ICANS prognosis: insights from GTE scoring

预CAR-T EEG异常的客观量化及其对ICANS预后的影响:GTE评分的见解

2025-04-280
PRE